Microbial Interactions in the Cystic Fibrosis Airway.

Area of Science:

• Microbiology and Immunology
• Infectious Diseases
• Pulmonology

Background:

• Cystic fibrosis (CF) airway infections involve complex microbial interactions.
• Understanding these interactions is crucial for optimizing clinical management and treatment strategies in CF patients.

Purpose of the Study:

• To investigate the longitudinal associations between common airway organisms in cystic fibrosis patients.
• To determine how the presence of one organism influences the subsequent presence of others in the CF airway ecosystem.

Main Methods:

• Utilized generalized estimating equations to model logistic regression on 2-year patient cohorts from the Cystic Fibrosis Foundation Patient Registry (2003-2011).
• Analyzed sputum culture data from 28,042 patients (aged 6+) across 257 U.S. care centers, covering 538,458 cultures.
• Adjusted models for clinical characteristics and tested sensitivity to CF-specific treatments.

Main Results:

• Methicillin-sensitive Staphylococcus aureus (MSSA) negatively associated with subsequent Pseudomonas aeruginosa.
• P. aeruginosa negatively associated with Burkholderia cepacia complex, Achromobacter xylosoxidans, and Stenotrophomonas maltophilia.
• B. cepacia complex negatively associated with all other studied bacteria and Aspergillus species; P. aeruginosa, B. cepacia complex, and S. maltophilia positively associated with Aspergillus species.

Conclusions:

• Microbial organisms in the CF airway exhibit significant interactions that influence their persistence and potentially clinical outcomes.
• MSSA's inhibition of P. aeruginosa may delay CF lung disease progression.
• P. aeruginosa and B. cepacia complex may reduce airway biodiversity, potentially exacerbating lung disease.